These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12941090)

  • 21. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
    Boissy RE; Visscher M; DeLong MA
    Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
    Cook-Bolden FE; Hamilton SF
    Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of cryotherapy vs. trichloroacetic acid in the treatment of solar lentigo.
    Raziee M; Balighi K; Shabanzadeh-Dehkordi H; Robati RM
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):316-9. PubMed ID: 18021205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of actinic lentigines due to multiple sub-erythemal exposure to UVA1 radiation in Asian skin.
    Morita A; Seité S; Le Dantec G; Kerob D
    Exp Dermatol; 2023 Nov; 32(11):2034-2037. PubMed ID: 37715544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological characterization of solar lentigines by in vivo reflectance confocal microscopy: a longitudinal approach.
    Pollefliet C; Corstjens H; González S; Hellemans L; Declercq L; Yarosh D
    Int J Cosmet Sci; 2013 Apr; 35(2):149-55. PubMed ID: 23075151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of topical treatment of pigmentation skin disorders with plant hydroquinone glucosides as assessed by quantitative color analysis.
    Clarys P; Barel A
    J Dermatol; 1998 Jun; 25(6):412-4. PubMed ID: 9675352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NB-UVB (311-312 nm)-induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy.
    Friedland R; David M; Feinmesser M; Barzilai A; Hodak E
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1158-62. PubMed ID: 21790796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of solar lentigines with trichloroacetic acid 40% vs. cryotherapy.
    Goldust M; Golforoushan F; Rezaee E
    Eur J Dermatol; 2011; 21(3):426-7. PubMed ID: 21684839
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of D-pigment dermocosmetic lightening product for solar lentigo lesions of the hand: A randomized controlled trial.
    Arginelli F; Greco M; Ciardo S; Josse G; Rossi AB; Le Digabel J; Questel E; Chester J; Pellacani G
    PLoS One; 2019; 14(5):e0214714. PubMed ID: 31042723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology of solar lentigines of the face: a quantitative study.
    Andersen WK; Labadie RR; Bhawan J
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):444-7. PubMed ID: 9091478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Black light visualized solar lentigines on the shoulders and upper back are associated with objectively measured UVR exposure and cutaneous malignant melanoma.
    Idorn LW; Datta P; Heydenreich J; Philipsen PA; Wulf HC
    Photochem Photobiol Sci; 2015 Feb; 14(2):481-7. PubMed ID: 25410723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Videomicroscopic and histopathological investigation of intense pulsed light therapy for solar lentigines.
    Kawada A; Asai M; Kameyama H; Sangen Y; Aragane Y; Tezuka T; Iwakiri K
    J Dermatol Sci; 2002 Aug; 29(2):91-6. PubMed ID: 12088609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color.
    Kawana S; Ochiai H; Tachihara R
    Dermatol Surg; 2007 Apr; 33(4):449-54. PubMed ID: 17430379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solar lentigines are strongly related to sun exposure in contrast to ephelides.
    Bastiaens M; Hoefnagel J; Westendorp R; Vermeer BJ; Bouwes Bavinck JN
    Pigment Cell Res; 2004 Jun; 17(3):225-9. PubMed ID: 15140067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling analysis of solar lentigo in relation to immunohistochemical characteristics.
    Aoki H; Moro O; Tagami H; Kishimoto J
    Br J Dermatol; 2007 Jun; 156(6):1214-23. PubMed ID: 17419692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of topical application of B-Resorcinol and Glycyrrhetinic acid monotherapy and in combination with fractional CO
    Grippaudo FR; Di Russo PP
    J Cosmet Dermatol; 2016 Dec; 15(4):413-419. PubMed ID: 27325103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical improvement of solar lentigines and ephelides with an intense pulsed light source.
    Kawada A; Shiraishi H; Asai M; Kameyama H; Sangen Y; Aragane Y; Tezuka T
    Dermatol Surg; 2002 Jun; 28(6):504-8. PubMed ID: 12081680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyspigmentation, skin physiology, and a novel approach to skin lightening.
    Draelos Z; Dahl A; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Cosmet Dermatol; 2013 Dec; 12(4):247-53. PubMed ID: 24305422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Objective assessment of intensive targeted treatment for solar lentigines using intense pulsed light with wavelengths between 500 and 635 nm.
    Tanaka Y; Tsunemi Y; Kawashima M
    Lasers Surg Med; 2016 Jan; 48(1):30-5. PubMed ID: 26462982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.